Mindray has announced it will be launching its new A8 and A9 anaesthesia machines in the UK market.
The two systems are the medical device manufacturer’s most advanced anaesthesia products to date, offering connectivity options and patient safety features.
Both the A8 and A9 are the first devices in the industry to have integrated high flow nasal cannula (HFNC) technology within the anaesthesia machine.
The feature helps extend the window of therapeutic action for anaesthetists by prolonging safe oxygenation levels, allowing up to 30 minutes of safe oxygenated apnoea time. Studies by the British Journal of Anaesthesia found that HFNC can more than double the average duration of apnoea before desaturation.
Data from a wide range of external monitoring modules such as bispectral index, neuromuscular transmission and intravenous imaging, can be seamlessly integrated and displayed by the new devices without any extra monitoring screens.
Enabling anaesthetists to collect more data at a glance, the modular design also fulfils the need for fewer devices in theatre, allowing anaesthetists to utilise a larger workspace and spend more time closely observing their patients.
A study in the Anesthesia & Analgesia journal found that anaesthesiologists look at their monitor in one to two second glances, therefore displays should be developed to optimise this short window of information.
In order to optimise gas usage and quickly provide a balanced response to changes in patient status without user intervention, the A9 uses Automatic Controlled Anaesthesia (ACA). Through its precision electronic vaporiser and ACA platform, the A9 adjusts fresh gas and vaporiser output to hit patient targets using both end-tidal and inspiratory oxygen measurements.
The new systems also utilise a suite of gas reduction tools to minimise the environmental and economic impact of surgery by preventing leakage and managing usage, improving patient safety in the process. Both the A8 and A9 can offer suggestions on optimal fresh gas flow, provide real-time usage metrics, pause to prevent leakage, and indicate flow rate abnormalities.
Mindray’s innovative volume exchanger design allows the two devices to deliver ICU-level ventilation, offering greater precision and protection for all patients during ventilation. The system has no moving parts and is supported by a range of protective ventilation tools, offering reliable and safe ventilation to reduce the occurrence of post-operative complications.
The devices demonstrate Mindray’s commitment to improving connectivity by easily connecting to existing devices and patient data management systems, from central workstations to bedside monitors. Both systems can also be configured for up to 10 individual patient profiles, an industry-first. This interconnected approach provides greater data visibility throughout the patient journey, minimising risks and improving patient care.
